Cargando…
EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance
Colorectal cancer is a serious threat to human health. Poor prognosis and frequently reported drug resistance urges research into novel biomarkers and mechanisms to aid in the understanding of the development and progression of colorectal cancer and to optimise therapeutic strategies. In the current...
Autores principales: | Zeng, Jianyuan, Sanders, Andrew J., Ye, Lin, Hargest, Rachel, Ruge, Fiona, Jiang, Wen G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736569/ https://www.ncbi.nlm.nih.gov/pubmed/36499558 http://dx.doi.org/10.3390/ijms232315232 |
Ejemplares similares
-
EPLIN: a fundamental actin regulator in cancer metastasis?
por: Collins, Ross J., et al.
Publicado: (2015) -
Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers
por: Zeng, Jianyuan, et al.
Publicado: (2021) -
EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance
por: Gong, Wenjing, et al.
Publicado: (2021) -
Implication of metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R in colorectal cancer
por: Ji, Ke, et al.
Publicado: (2014) -
Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressor
por: Wu, Daqing
Publicado: (2017)